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ABSTRACT 
Marine sponge is known as a “gold mine” of natural products from marine environment. Many 
novel bioactive compounds have been isolated from marine sponges and sponge-associated 
microorganisms such as antibiotics, anti-cancer compounds, protease inhibitors, etc. In this 
study, we selected a gene encoding protease inhibitor from metagenome of a sponge collected 
in Quang Tri to express in Escherichia coli (E. coli) BL21(DE3). The gene PI-DN9 encoding 
protease inhibitor (1.3 kb) was cut off cloning vector pUC57/PI-DN9 containing gene PI-DN9 
and inserted into expression vector pET-32a(+), the recombinant vector pET-32a(+)/PI-DN9 
then was transformed and expressed in the E. coli strain BL21(DE3). Results showed that 
recombinant protein (50 kDa) was expressed successfully at 25°C, 1 mM of IPTG in 5 hours. 
The recombinant protein was purified using Ni-NTA affinity chromatography column. Western 
blot assay and bioactive assay showed good activity of the purified protein. 
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INTRODUCTION 
Proteases are important enzymes in host 
cells and responsible for many physiological 
functions, such as zymogene activation, 
coagulation, fibroblast fibrinolysis, hormone 
and bioactive peptide release, etc. However, 
the loss of control of proteolysis can cause 
cancer and cardiovascular diseases, 
inflammation, neuro degeneration as well as 
bacterial, viral and parasitic diseases. 
Nowadays, protease inhibitors are often used 
for treatment of diseases related to proteases. 
Therefore, discovery of novel protease 
inhibitors is still a special interest of scientists 
(Barrett et al., 1998; Agbowuro et al., 2017). 
Metagenomics is new approach that 
allowsstudying genetic materials recovered 
directly from environment samples. To date, 
metagenomics has been used for finding novel 
bioactive compounds as well as investigating 
diversity of microorganisms from different 
environments. Particularly, studies focus on 
discovery of genes encoding potential 
bioactive compounds for bio-pharmaceutical 
field from marine microorganisms. Many 
protease inhibiors and other bioactive second 
metabolites have found from metagenome 
database (Baharum et al., 2010; Culligan et 
al., 2014; He et al., 2013).  
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In this study, we selected a novel gene 
encoding protease inhibitor from metagenome 
of marine sponge QT  collected in Quang Tri 
and expressed in the Escherichia coli (E. coli) 
strain BL21(DE3) for finding and mining 
novel protease inhibitor. 
MATERIALS AND METHODS 
Cloning vector pUC57 (Genscript, USA) 
inserted gene PI-DN9 from metagenome of 
the sponge QT; expression vector pET-
32a(+); strain E. coli Top10F’; strain E. coli 
BL21(DE3) (Invitrogen, USA); restriction 
enzyme EcoRI, NotI and DNA marker 
(Fermentas, USA); protein markers (Novagen, 
Netherlands; Sigma-Aldrich, USA, iNtRON 
Biotechnology, Korea; Affymetrix, USA); 
Thrombin (Novagen, The Netherlands); 
Skimmed milked (Difco, USA); trypsin, ɑ-
chymotrypsin, thermolysin, IPTG, NBT 
(Sigma-Aldrich, USA). 
Construction of recombinant vector  
pET-32a(+)/PI-DN9 
Metagenome of the sponge QT was 
sequenced and annotated using databases, 
such as CAZy (Cantarel et al., 2009), GO 
(Ashbumer et al., 2006), COG, SWISSPROT, 
KEGG (Tatusov et al., 2001) and tools such as 
dbCAN (Yin et al., 2112), Prodigal (Hyatt et 
al., 2010) and MetageneMark (Zhu et al., 
2010) by BaseClear (Netherlands). The contig 
00046 (prokka 10704) having similarity 50% 
with genes encoding protease inhibitor on 
GeneBank was selected for protein 
expression. The sequence of contig 00046 was 
designed to contain two restriction enzymes 
EcoRI and NotI (PI-DN9) and inserted in 
cloning vector pUC57. The gene PI-DN9 was 
cut from cloning vector pUC57/PI-DN9 using 
enzymes EcoRI và NotI. The expression 
vector pET-32a(+) was also cut using two 
above enzymes. Finally, the gene PI-DN9 was 
inserted into expression vector pET-32a(+) in 
order to create recombinant vector pET-
32a(+)/PI-DN9. 
Expression of the gene PI-DN9 in E. coli 
BL21(DE3) 
The recombinant vector pET-32a(+)/PI-
DN9 was transformed into E.coli BL21(DE3) 
competent cells by the heat shock method. 
The strain E.coli BL21(DE3) containing the 
recombinant vector was incubated for 
overnight in LB medium supplemented with 
50 μg/mL of ampicillin (LBamp) at 37°C and 
shaked at 200 rpm. Culture broth was 
transferred into fresh Lbamp medium and 
incubated in the same above conditions  
until OD600 = 0.6, then added 1mM  
of Isopropylthio-ß-galactosida (IPTG) into 
culture broth and expressed at 25°C in 5 
hours. The expressed protein was checked on 
12.6% SDS-PAGE gel.  
Western blot assay  
In this study, Western blot assay was used 
to detect protease inhibitory protein. Protein 
was separated on 12.6% SDS-PAGE gel  
then transferred onto nitrocellulose or 
polyvinylidenedifluoride (PVDF) membrance 
by liquid blotting system (Invitrogen). The 
membrance was blocked with 5% milk in 
TBS for overnight and was incubated with 
antibody anti-TRx at 4°C (1:1000) for 2 
hours. The membrance then was placed in 
TBS buffer and washed for 10 minutes. Next, 
the membrance was incubated with the 
secondary antibody solution for 1 hours at 
room temperature, then was placed in TBS 
and washed for 10 minutes. This step was 
repeated twice with fresh buffer. Finally, the 
NBT substrate was added onto membrance to 
visualize the protein activity. 
Determination of protein in supernatant 
and pellet 
Culture broth was centrifuged at 5000 rpm 
for 5 minutes and removed supernatant. The 
pellet was resuspended in TE buffer (20mM 
Tris, 10mM EDTA, 0.05mM PMF) and 
incubated at  (-)80°C for 1 hour. The pellet 
was thawed at 50°C in 30 minutes and 
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disrupted by ultrasound. The solution was 
centrifuged at 13.000 rpm for 15 minutes. The 
supernatant was collected, and the pellet was 
resuspended again in TE buffer. Finally, SDS 
loading bufferwas added into culture broth 
before centrifugating. After centrifugating, 
supernatant and the pellet were deraturated at 
100°C for 10 minutes. The expression protein 
was checked on 12.6% SDS-PAGE gel. 
Purification of protein PI-DN9 
The recombinant protein was purified by 
Invitrogen
TM
 Novex
TM
 Ni-NTA purification 
system according to manufacture’s protocol. 
Then, the purified protein was then cut off 
TRx-His tagusing Thrombin Kit (Novagen, 
The Netherlands).  
Primary screening of protease inhibitory 
activity of protein 
Protease inhibitory activity of the 
recombinant protein was performed in 
skimmed milk agar plate (0.8% agar, 1% 
skimmed milked) with wells made in centre 
and periphery at a distance of 1 cm from the 
central well. Twenty microlitres of proteases 
(trypsin, or ɑ-chymotrypsin, or thermolysin at 
0.5mg/ml) were pipetted in the central well. 
The recombinant protein was added in one of 
the peripheral wells and sterile distilled water 
(negative control) in the other. The plate was 
incubated at 37°C. The inhibitory activity was 
detected by absence of clearance zone around 
the well containing the inhibitor (Sapna, 
2013).  
Protease inhibitory assay of the  
recombinant protein 
The recombinant protein was added to a 
mixture of chloride, phosphate buffer and 
protease solutions (trypsin, or ɑ-
chymotrypsin, or thermolysin). After 
adjusting the pH to 7.5, BAPNA (N-ɑ-
benzoyl-DL-arginine-p-nitroanilide) was 
added into the mixture and incubated at 37°C 
for 20 minutes. Next, 5% TCA was added into 
the solution and incubated at room 
temperature for 20 minutes. Finally, the 
solution was filtered with Whatman no. 1 
filter paper and the absorbance was measured 
at 280 nm. The inhibiting activity of protease 
inhibitor was calculated following formula: 
Inhibiting activity (%)= C–T/C × 100 
C was absorbance value of blank sample 
and T was absorbance value of samples with 
protease inhibitor (Karthik et al., 2014).   
RESULTS AND DISCUSSION 
Construction of recombinant vector pET-
32a(+)/PI-DN9 
The gene PI-DN9 was cut from plasmid 
pUC57/PI-DN9 using restriction enzymes 
EcoRI and NotI. The vector pET-32a(+) was 
also digested with EcoRI and NotI (Fig. 1A). 
The products were then purified and checked 
on 1% agarose gel (Fig. 1B). Agarose gel 
analysis showed that there was a band with 
size of 6 kb at lane 1 and lane 3 which was 
similar to the size of vector pET-32a(+). The 
band with size of 2.7 kb at lane 2 was similar 
to the size of vector pUC57 and the band in 
lane 4 with the size of 1.3 kb was similar to 
the size of gene PI-DN9. 
The gene PI-DN9 was inserted into vector 
pET-32a(+) using T4 ligase, then transformed 
into strain E. coli Top10F’ competent cells 
and incubated in LB medium containing 1mM 
ampicillin. Some colonies were randomly 
picked for plasmid extraction and then 
digested with EcoRI và NotI. The cutting 
products were checked on 1% agarose gel 
(Fig. 2). 
The results showed that, the presenced 
bands with 1.3kb in size at lane 1 and 2 (Fig. 
2) were similar to the size of the gene PI-DN9 
(1.3kb). Besides, we detected other bands 
with 6kb in size at lane 1 and 2 were similar 
to the size of the vector pET-32a(+) without 
gene PI-DN9 at lane C. This result indicated 
that gene PI-DN9 may be inserted 
successfully into vector pET-32a(+). To 
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confirm this, we sequenced recombinant 
plasmid and result showed that the sequenced 
gene was similar 100% with gene PI-DN9 
(data not shown). Therefore, the expression 
vector pET-32a(+)/PI-DN9 was successfully 
constructed. 
 
Figure 1. (A) Agarose gel analysis of vector pET-32a(+) and vector pUC57/PI-DN9 cut with 
EcoRI andNotI, (B) Purified products. Lane M: Maker 1 kb (Thermo), Lane 1(A): opened 
vector pET-32a(+) after cut with EcoRI andNotI, Lane 3: purified vector pET-32a(+), Lane 
2(A): opened vector pUC57/PI-DN9 cut with EcoRI and NotI, Lane 4: purified gene PI-DN9 
 
 
Figure 2. Agarose gel analysis of recombinant 
plasmid cut with EcoRI and NotI. lane  
M: marker 1 kb (Thermo); lane 1: plasmid 
pET-32a(+)/PI-DN9; lane 2, 3, 4: plasmid 
pET-32a(+)/PI-DN9 was cut by enzymes 
EcoRI/NotI; lane 5: vector pET-32a(+) 
Expression of recombinant protein in  
E. coli BL21(DE3) 
The recombinant vector pET-32a(+)/PI-
DN9 was transformed into E. coli BL21(DE3) 
competent cells and incubated in LB medium 
with 1mM (amp). The presence of white 
colonies on plate indicated the recombinant 
vector may be transformed successfully in  
E. coli BL21(DE3). To confirm this, we 
picked randomly 3 colonies and expressed 
recombinant protein as described in the 
methods section (Fig. 3). 
 
Figure 3. Colonies of E. coli BL21(DE3)  
containing recombinant vector pET- 
32a(+)/PI-DN9 on LBamp medium  
Expressed recombinant protein was 
checked on SDS-PAGE gel and stained with 
Coomassie (Fig. 4A). The result showed that 
colonies induced with IPTG appeared an extra 
band with the size of 64 kDa, which is similar 
with the size of protein PI-DN9 attached  
TRx-His tag (Fig. 4A: lane 3,5,7). Lane 1 
(only vector pET-32a(+) and lane 2, 4, 6 
(colonies were not induced with IPTG) did 
not have this extra band. To confirm the 
expression abilities of recombinant protein, 
we selected one clone and performed Western 
blot assay with the specific anti-TRx antibody. 
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Western blot analysis showed a band with the 
size of 64 kDa, which was similar to the result 
of SDS-PAGE analysis. Therefore, we 
confirmed that the recombinant protein was 
expressed successfully.  
In order to determine the fraction of
expression protein, the recombinant protein in 
the supernatant and pellet fractions were 
denatured and checked on 12.6% SDS-PAGE 
gel. The SDS-PAGE analysis showed that the  
recombinant protein was expressed mainly in 
supernatant fraction (Fig. 4C, lane T). 
 
Figure 4. Analysis of protein expression on SDS-PAGE gel: (A) Protein expression PI-DN9 at 
25°C and 1 mM of IPTG (Lane 1: clone without gen PI-DN9, Lane 2, 4, 6: clones containing Pet-
32a(+)/PI-DN9 without induction with IPTG, Lane 3, 5, 7: clones containing pET-32a(+)/PI-DN9 
induced with IPTG, Lane M: protein maker, (B) Western blot reaction of protein PI-DN9 with 
TRx (Land KT), (C) Protein expression in cultrure broth (TC), in pellet (C), in supernatant (T)  
 
Purification of expressed protein and  
determination of its protease inhibitory  
activity  
The vector pET-32a(+) contained the 
sequence of Hig-tag was used for protein 
expression, thereby the recombinant protein 
was purified by affinity chromatographic 
method using Ni-NTA purification system, 
then the purified protein fractions were 
checked on 12.6% SDS-PAGE gel. The result 
showed that, the recombinant protein PI-DN9 
was in stage 1 and 2. However, amount of 
purified protein in stage 1was higher than in 
stage 2 (Fig. 5A). 
In order to test protease inhibitory activity 
of the expressed protein, the sequence of TRx-
His tag was removed from the purified protein 
using thrombin. The SDS-PAGE analysis of 
the protein treated with thrombin revealed the 
presence of two bands: one band had size of 
50 kDa (size of protein PI-DN9) and one band 
with size of 14 kDa (size of TRx-His tag)(Fig. 
5B). Therefore, we removed successfully 
TRx-His tag from the expressed protein. 
Activity assay results of expressed protein 
against proteases (trypsin, ɑ-chymotrypsin, 
thermolysin) using skimmed milked plate 
showed that protein PI-DN9 displayed 
inhibitory activity against trypsin (Fig. 6), but 
did not inhibit against ɑ-chymotrypsin and 
thermolysin. Protease inhibitory assay 
indicated that inhibitory activity of protein 
against trypsin reached 83%. 
There are some studies focused on 
discovery of protease inhibitory proteins from 
microorganisms associated with marine 
sponge; however, most of them use 
cultivation-dependent approaches (Wahyudi 
et al., 2010; Tabares et al., 2011; Pimentel-
Elardo et al., 2011; Ramadan et al., 2012). 
With rapid development of advance 
sequencing technology, scientists begin 
discovering and mining novel natural products 
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based on metagenomics instead of traditional 
cultivation. For example, Jiang et al. (2011) 
cloned successfully a novel protease 
inhibition gene against serine (Spi1C) based 
on metagenome of marine microorganisms. 
The gene Spi1C had ORF with 642 bp and 
encoded for 214 amino acid with estimated 
size of 28.7 kDa. The protein Spi1C displayed 
inhibitory activity against serine proteases 
such as α-chymotrypsin và trypsin. 
 
Figure 5. Analysis of the expressed protein after purifying on SDS-PAGE gel: (A) Fractions of 
expressed protein after purifying with Ni-NTA column (Lane M: protein marker (Bio-basic), 
Lane 1: protein without induced with IPTG, Lane 2: protein induced with IPTG, Lane 3: protein 
before purifying, Lane 4: protein after purifying with Ni-NTA column, Lane5: protein after 
column treated with imidazole 100 mM, Lane 6-10: proteine fractions after treating column with 
imidazole 250mM), (B) Protein expression after cut TRx-His (Land C), before cutting TRx-His 
(Lane CC) and protein maker of Bio-basic (M) 
 
 
Figure 6. Protease inhibitor assay on plate 
(A) protein with TRx-His tag, (B) protein  
removed TRx-His tag 
CONCLUSION 
A novel gene encoding protease inhibitor 
PI-DN9 from metagenome of a sponge in 
Quang Tri was expressed successfully in E. 
coli BL21(DE3). The purified protein 
displayed inhibitory activity against trypsin 
with 83% inhibition activity. Our study 
showed that metagenomics is a potential tool 
for discovery and exploitation of novel 
protease inhibitor from uncultivable 
microorganisms. 
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